Betaferon® – Ab Ovo

por Limmroth, Volker
Publicado 2013

Eine Impfung gegen Multiple Sklerose?

por Limmroth, Volker
Publicado 2021

Medizinischer Fortschritt trotz COVID-19

por Limmroth, Volker, Diener, Hans-Christoph
Publicado 2021

NeuroLive - Video-on-demand für die Neurologie

por Meier, Uwe, Limmroth, Volker, Grond, Martin
Publicado 2022

Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp)

por Limmroth, Volker, Hechenbichler, Klaus, Müller, Christian, Schürks, Markus
Publicado 2019

Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observational Stud...

por Limmroth, Volker, Bayer-Gersmann, Kirsten, Mueller, Christian, Schürks, Markus
Publicado 2022

Correction: Ascertaining Medication Use and Patient-Reported Outcomes via an App and Exploring Gamification in Patients With Multiple Sclerosis Treated With Interferon β-1b: Observ...

por Limmroth, Volker, Bayer-Gersmann, Kirsten, Mueller, Christian, Schürks, Markus
Publicado 2022

CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS

por Limmroth, Volker, Barkhof, Frederik, Desem, Nuket, Diamond, Mark P., Tachas, George
Publicado 2014

A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?

por Brotons, Carlos, Benamouzig, Robert, Filipiak, Krzysztof J., Limmroth, Volker, Borghi, Claudio
Publicado 2014

Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort stu...

por Zettl, Uwe K, Bauer-Steinhusen, Ulrike, Glaser, Thomas, Hechenbichler, Klaus, Limmroth, Volker
Publicado 2013

Prehospital Levetiracetam Use in Adults With Status Epilepticus: Results of a Multicenter Registry

por Burghaus, Lothar, Madlener, Marie, Kohle, Felix, Bruno, Emanuel F., Limmroth, Volker, Fink, Gereon R., Malter, Michael P.
Publicado 2023

Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry

por Kohle, Felix, Madlener, Marie, Bruno, Emanuel Francesco, Fink, Gereon Rudolf, Limmroth, Volker, Burghaus, Lothar, Malter, Michael Peter
Publicado 2022

Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program

por Katsarava, Zaza, Ehlken, Birgit, Limmroth, Volker, Taipale, Kirsi, Patel, Sarita Noemi, Niemczyk, Gabriele, Rehberg-Weber, Karin, Wernsdörfer, Colin
Publicado 2015

Case Report: Human Bocavirus Associated Pneumonia as Cause of Acute Injury, Cologne, Germany

por Krakau, Michael, Gerbershagen, Kathrin, Frost, Ulrich, Hinzke, Markus, Brockmann, Michael, Schildgen, Verena, Goßmann, Axel, Limmroth, Volker, Dormann, Arno, Schildgen, Oliver
Publicado 2015

A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes

por Limmroth, Volker, Ziemssen, Tjalf, Kleiter, Ingo, Wagner, Bert, Schmidt, Stephan, Lassek, Christoph, Baier-Ebert, Monika, Wendt, Guillaume, Dechend, Ralf, Haverkamp, Wilhelm
Publicado 2020

Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of Cisplatin-induced neuropathy

por Yoon, Min-Suk, Katsarava, Zaza, Obermann, Mark, Schäfers, Maria, Liedert, Bernd, Dzagnidze, Anna, Kribben, Andreas, Egensperger, Rupert, Limmroth, Volker, Diener, Hans-Christoph, Thomale, Juergen
Publicado 2009

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple s...

por Ziemssen, Tjalf, Gass, Achim, Wuerfel, Jens, Bayas, Antonios, Tackenberg, Björn, Limmroth, Volker, Linker, Ralf, Mäurer, Mathias, Haas, Judith, Stangel, Martin, Meergans, Matthias, Harlin, Olof, Hartung, Hans-Peter
Publicado 2016

Electrocardiographic assessments and cardiac events after fingolimod first dose – a comprehensive monitoring study

por Limmroth, Volker, Ziemssen, Tjalf, Lang, Michael, Richter, Stephan, Wagner, Bert, Haas, Judith, Schmidt, Stephan, Gerbershagen, Kathrin, Lassek, Christoph, Klotz, Luisa, Hoffmann, Olaf, Albert, Christian, Schuh, Katrin, Baier-Ebert, Monika, Wendt, Guillaume, Schieb, Heinke, Hoyer, Susanne, Dechend, Ralf, Haverkamp, Wilhelm
Publicado 2017

Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study

por Ziemssen, Tjalf, Bass, Ann D., Berkovich, Regina, Comi, Giancarlo, Eichau, Sara, Hobart, Jeremy, Hunter, Samuel F, LaGanke, Christopher, Limmroth, Volker, Pelletier, Daniel, Pozzilli, Carlo, Schippling, Sven, Sousa, Livia, Traboulsee, Anthony, Uitdehaag, Bernard M. J., Van Wijmeersch, Bart, Choudhry, Zia, Daizadeh, Nadia, Singer, Barry A.
Publicado 2020

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studi...

por Comi, Giancarlo, Alroughani, Raed, Boster, Aaron L, Bass, Ann D, Berkovich, Regina, Fernández, Óscar, Kim, Ho Jin, Limmroth, Volker, Lycke, Jan, Macdonell, Richard AL, Sharrack, Basil, Singer, Barry A, Vermersch, Patrick, Wiendl, Heinz, Ziemssen, Tjalf, Jacobs, Alan, Daizadeh, Nadia, Rodriguez, Claudio E, Traboulsee, Anthony
Publicado 2019